COVID-19 Virus Infection Clinical Trial
Official title:
SafeTy and Efficacy of Preventative CoVID Vaccines
The STOPCoV study is a decentralized study comparing COVID-19 vaccine specific antibody levels at 24 weeks after final vaccine dose. We plan to study the safety and immunogenicity of COVID-19 vaccine(s) in community dwelling persons 70 years and over relative to a younger group (aged 30 - 50 years).
This is a prospective observational study of a cohort of individuals aged 30-50 years and a cohort of individuals aged 70 years and over receiving the COVID-19 vaccine. Participants will complete a questionnaire to determine eligibility. Eligible participants will complete and sign an e-consent and then be provided with a participant ID, log in information and password to the database portal, and then be enrolled into the study. Participants will complete the study assessments (baseline questionnaire, post vaccine symptom e-diary monthly, check-in questionnaire and dried blood spot specimens) ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04560881 -
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)
|
Phase 3 | |
| Terminated |
NCT04449380 -
Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients
|
Phase 2 | |
| Completed |
NCT05364268 -
Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation
|
||
| Completed |
NCT05268679 -
Covid-19 Vaccine Response in Heart Transplant Recipients
|
||
| Completed |
NCT05446961 -
Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus
|
Phase 2 | |
| Terminated |
NCT04847583 -
A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients
|
Phase 2 | |
| Terminated |
NCT04778059 -
Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
|
Phase 2 | |
| Terminated |
NCT04786808 -
Risk Factors for COVID-19 Mortality
|
||
| Completed |
NCT05514691 -
Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC
|
N/A | |
| Withdrawn |
NCT05085574 -
Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
|
Phase 2 | |
| Completed |
NCT05489367 -
Does COVİD-19 m-RNA Vaccine Affect Fertility and Over Reserve ?
|
||
| Withdrawn |
NCT05133635 -
High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
|
Phase 4 | |
| Active, not recruiting |
NCT05077332 -
LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
|
Phase 2 | |
| Terminated |
NCT05077969 -
Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)
|
Phase 2 | |
| Completed |
NCT05371561 -
Effect of PPE on Children's Fear in Dental Office
|
N/A |